Study of Rivoglitazone in Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT00484198. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo and Active Comparator-Controlled, Parallel-Group Study of the Efficacy and Safety of Rivoglitazone as Monotherapy Treatment of Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 26-week study in subjects with type 2 diabetes currently sub-optimally controlled by diet and exercise or with non-thiazolidinedione antihyperglycemic monotherapy. The total duration of a subject's participation will be approximately 30 weeks, including a 2-week placebo run-in period, a 26-week double-blind treatment period, and a 2-week post-treatment follow-up period.
Study identification
- NCT ID
- NCT00484198
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,912 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 23, 2007 (Actual)
- Primary completion
- Feb 12, 2009 (Actual)
- Completion
- Feb 12, 2009 (Actual)
- Last update posted
- Jul 27, 2021
2007 – 2009
United States locations
- U.S. sites
- 70
- U.S. states
- 28
- U.S. cities
- 70
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anniston | Alabama | — | — |
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Hoover | Alabama | — | — |
| Not listed | Muscle Shoals | Alabama | — | — |
| Not listed | Hot Springs | Arkansas | — | — |
| Not listed | Jonesboro | Arkansas | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Buena Park | California | — | — |
| Not listed | Garden Grove | California | — | — |
| Not listed | Huntington Park | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Paramount | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Walnut Creek | California | — | — |
| Not listed | West Covina | California | — | — |
| Not listed | West Hills | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Delray Beach | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Merritt Island | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Honolulu | Hawaii | — | — |
| Not listed | Boise | Idaho | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Madisonville | Kentucky | — | — |
| Not listed | New Orleans | Louisiana | — | — |
| Not listed | Slidell | Louisiana | — | — |
| Not listed | Springfield | Massachusetts | — | — |
| Not listed | Portage | Michigan | — | — |
| Not listed | Southfield | Michigan | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Voorhees Township | New Jersey | — | — |
| Not listed | Syracuse | New York | — | — |
| Not listed | Morehead City | North Carolina | — | — |
| Not listed | Salisbury | North Carolina | — | — |
| Not listed | Statesville | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Delaware | Ohio | — | — |
| Not listed | Lyndhurst | Ohio | — | — |
| Not listed | Marion | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Beaver | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Columbia | South Carolina | — | — |
| Not listed | Cleveland | Tennessee | — | — |
| Not listed | Kingsport | Tennessee | — | — |
| Not listed | New Tazewell | Tennessee | — | — |
| Not listed | Carrollton | Texas | — | — |
| Not listed | Conroe | Texas | — | — |
| Not listed | Corpus Christi | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | El Paso | Texas | — | — |
| Not listed | Garland | Texas | — | — |
| Not listed | Irving | Texas | — | — |
| Not listed | Midland | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Olympia | Washington | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 113 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00484198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2021 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00484198 live on ClinicalTrials.gov.